Report an error

Spotted something inaccurate in “Phase 1 Bispecific Antibody Trial Shows Lupus Disease Activity Improvements”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.